Arama Sonuçları - Avivi, Irit
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 38
- Sonraki Sayfaya Git
-
1
Hematological malignancies during pregnancy Yazar: Barzilai, Merav, Avivi, Irit, Amit, Odelia
Baskı/Yayın Bilgisi 2019Metin -
2
Dendritic Cell Cancer Vaccines: From the Bench to the Bedside Yazar: Katz, Tamar, Avivi, Irit, Benyamini, Noam, Rosenblatt, Jacalyn, Avigan, David
Baskı/Yayın Bilgisi 2014Metin -
3
-
4
Soluble plasma HLA peptidome as a potential source for cancer biomarkers Yazar: Bassani-Sternberg, Michal, Barnea, Eilon, Beer, Ilan, Avivi, Irit, Katz, Tami, Admon, Arie
Baskı/Yayın Bilgisi 2010Metin -
5
-
6
New Rising Infection: Human Herpesvirus 6 Is Frequent in Myeloma Patients Undergoing Autologous Stem Cell Transplantation after Induction Therapy with Bortezomib Yazar: Horowitz, Netanel, Oren, Ilana, Lavi, Noa, Zuckerman, Tsila, Benyamini, Noam, Kra-Oz, Zipi, Held, Viki, Avivi, Irit
Baskı/Yayın Bilgisi 2012Metin -
7
Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy Yazar: Cohen, Dan, Hazut Krauthammer, Shir, Cohen, Yael C., Perry, Chava, Avivi, Irit, Herishanu, Yair, Even-Sapir, Einat
Baskı/Yayın Bilgisi 2021Metin -
8
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma Yazar: Markus, Efrat, Trestman, Svetlana, Cohen, Yael, Angel, Yoel, Sofer, Yael, Mittelman, Moshe, Avivi, Irit, Stern, Naftali, Izkhakov, Elena
Baskı/Yayın Bilgisi 2020Metin -
9
-
10
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience Yazar: Ram, Ron, Scheid, Christof, Amit, Odelia, Chemnitz, Jens Markus, Moshe, Yakir, Hallek, Michael, Wolf, Dominik, Avivi, Irit, Holtick, Udo
Baskı/Yayın Bilgisi 2019Metin -
11
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hod... Yazar: Dann, Eldad J., Bar-Shalom, Rachel, Tamir, Ada, Epelbaum, Ron, Avivi, Irit, Ben-Shachar, Menachem, Gaitini, Diana, Rowe, Jacob M.
Baskı/Yayın Bilgisi 2010Metin -
12
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia Yazar: Shapiro, Mika, Herishanu, Yair, Katz, Ben-Zion, Dezorella, Nili, Sun, Clare, Kay, Sigi, Polliack, Aaron, Avivi, Irit, Wiestner, Adrian, Perry, Chava
Baskı/Yayın Bilgisi 2017Metin -
13
Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19 Yazar: Sarid, Nadav, Mann, Shir, Herishanu, Yair, Perry, Chava, Cohen, Yael C, Passage, Inna, Neaman, Miriam, Benyamini, Noam, Jean, Maayan, Avivi, Irit
Baskı/Yayın Bilgisi 2021Metin -
14
Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia Yazar: Herishanu, Yair, Avivi, Irit, Levi, Shai, Shefer, Gabi, Bronstein, Yotam, Moshiashvili, Miguel Morales, Ziv, Tomer, Scarfò, Lydia, Perry, Chava, Ghia, Paolo
Baskı/Yayın Bilgisi 2022Metin -
15
The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma Yazar: Perry, Chava, Lerman, Hedva, Joffe, Erel, Sarid, Nadav, Amit, Odelia, Avivi, Irit, Kesler, Mikhail, Ben-Ezra, Jonathan, Even-Sapir, Einat, Herishanu, Yair
Baskı/Yayın Bilgisi 2016Metin -
16
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the rando... Yazar: Lugtenburg, Pieternella, Avivi, Irit, Berenschot, Henriette, Ilhan, Osman, Marolleau, Jean Pierre, Nagler, Arnon, Rueda, Antonio, Tani, Monica, Turgut, Mehmet, Osborne, Stuart, Smith, Rodney, Pfreundschuh, Michael
Baskı/Yayın Bilgisi 2017Metin -
17
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells Yazar: Shorer Arbel, Yamit, Katz, Ben-Zion, Gabizon, Ronen, Shraga, Amit, Bronstein, Yotam, Kamdjou, Talia, Globerson Levin, Anat, Perry, Chava, Avivi, Irit, London, Nir, Herishanu, Yair
Baskı/Yayın Bilgisi 2021Metin -
18
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single... Yazar: Vitkon, Roy, Netanely, Dan, Levi, Shai, Ziv-Baran, Tomer, Ben-Yzak, Ronit, Katz, Ben-Zion, Benyamini, Noam, Trestman, Svetlana, Mittelman, Moshe, Cohen, Yael, Avivi, Irit
Baskı/Yayın Bilgisi 2021Metin -
19
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia Yazar: Herishanu, Yair, Avivi, Irit, Aharon, Anat, Shefer, Gabi, Levi, Shai, Bronstein, Yotam, Morales, Miguel, Ziv, Tomer, Shorer Arbel, Yamit, Scarfò, Lydia, Joffe, Erel, Perry, Chava, Ghia, Paolo
Baskı/Yayın Bilgisi 2021Metin -
20
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituxima... Yazar: Tadmor, Tamar, Bari, Alessia, Sacchi, Stefano, Marcheselli, Luigi, Liardo, Eliana Valentina, Avivi, Irit, Benyamini, Noam, Attias, Dina, Pozzi, Samantha, Cox, Maria Christina, Baldini, Luca, Brugiatelli, Maura, Federico, Massimo, Polliack, Aaron
Baskı/Yayın Bilgisi 2014Metin